Florensis has obtained the rights from Express Seed to sell and produce Syngenta genetics in Europe in 2023. The acquisition of Syngenta Poinsettia genetics by Express Seed in America has made this possible.
Wim Mieremet, Corporate Product Manager Cuttings, is very happy with this development. "Sales will start in 2023, among which the key varieties from these genetics like Titan, Mars, Mira, and Mirage. This makes our Poinsettia assortment even more attractive to our customers. The mother stock production will take place at one of our production locations in Ethiopia. Our partner P. van der Haak in The Netherlands becomes responsible for the young plants production."
Next year Florensis will present the best varieties from Decock Plants, Lazzeri, and Syngenta breeding, to offer a complete range to our customers.